Homecare Medicines Services - High Tech Framework including Lot A Compounded Desferrioxamine

The procurement contact named on the official notice.

Framework agreement for the provision of high tech homecare medicines services (including lot A compounded desferrioxamine) to members of the Yorkshire and Humber NHS Pharmaceutical Purchasing Consortium, and other organisations with prior approval only.

This framework will be subject to the release of mini competitions for specific high homecare services.

Services are to be provided in line with the Royal Pharmaceutical Society Professional Standards for Homecare.

This framework agreement will be accessible to all partly or wholly publically funded bodies in the United Kingdom, including Northern Ireland, Scotland, Wales and England.

This will include, but is not limited to: Acute; (including their third party providers); Ambulance; Mental Health; Clinical Commissioning Groups; Health and Care Trusts; Area Teams; Local Authorities and Special Health Authorities; HSC in Northern Ireland; NHS Scotland and NHS Wales, including any successor or emerging organisations, which will include but is not limited to the emerging landscape of combined health and social care commissioners and providers.